--- title: "Novo Holdings cuts MapLight stake below 5%" url: "https://aibio.space/news/novo-holdings-cuts-maplight-stake-below-5-percent-after-july-30-share/" publisher: "aibio.space (Biotech Investor Relations News)" date: "2026-07-30" section: "Financings" tickers: "NASDAQ:MPLT" source: "https://www.sec.gov/Archives/edgar/data/1770069/000138832526000034/xslSCHEDULE_13D_X02/primary_doc.xml" summary: "The Danish investor sold 1.6 million shares in open-market trades at $12.00 to $15.00 and reported 2,086,622 shares left, about 4.9%." --- By the aibio.space news desk. Sources - [MPLT SCHEDULE 13D/A](https://www.sec.gov/Archives/edgar/data/1770069/000138832526000034/xslSCHEDULE_13D_X02/primary_doc.xml) - [MPLT DEF 14A](https://www.sec.gov/Archives/edgar/data/1770069/000119312526191449/d121249ddef14a.htm) [MPLT](https://aibio.space/companies/maplight-therapeutics/) 2026-07-30 # Novo Holdings cuts MapLight stake below 5% after July 30 share sales Tickers [MPLT](https://aibio.space/companies/maplight-therapeutics/) The Danish investor sold 1.6 million shares in open-market trades at $12.00 to $15.00 and reported 2,086,622 shares left, about 4.9%. ## Key facts - **Company**: MapLight Therapeutics, Inc. (NASDAQ: MPLT) - **News type**: Financings - **Primary source**: [MPLT SCHEDULE 13D/A](https://www.sec.gov/Archives/edgar/data/1770069/000138832526000034/xslSCHEDULE_13D_X02/primary_doc.xml) *Trading screens with price charts. CC0, via rawpixel. The picture shows the field, not the companies named.* Novo Holdings A/S reported that it [fell below five percent beneficial ownership of MapLight Therapeutics common stock on 2026-07-30](https://www.sec.gov/Archives/edgar/data/1770069/000138832526000034/xslSCHEDULE_13D_X02/primary_doc.xml). The amended Schedule 13D described open-market share sales on that date. The sales were between Novo Holdings and the market, so MapLight received no money from them. The schedule reported a [remaining position of 2,086,622 shares, or approximately 4.9%](https://www.sec.gov/Archives/edgar/data/1770069/000138832526000034/xslSCHEDULE_13D_X02/primary_doc.xml) of the voting common stock. The filing describes Novo Holdings as a Danish corporation wholly owned by a foundation. ## The details The largest sale was [1,314,195 shares in a single transaction at $12.00 per share](https://www.sec.gov/Archives/edgar/data/1770069/000138832526000034/xslSCHEDULE_13D_X02/primary_doc.xml). Novo Holdings also sold [220,723 shares at prices from $13.55 to $14.54, with a $14.19 weighted average](https://www.sec.gov/Archives/edgar/data/1770069/000138832526000034/xslSCHEDULE_13D_X02/primary_doc.xml), and 65,082 shares at prices from $14.55 to $15.00, with a $14.69 weighted average. In total it sold 1,600,000 shares on the day (our arithmetic), which implies a position of 3,686,622 shares before the sales. Novo Holdings reported [sole voting and dispositive power over the remaining shares](https://www.sec.gov/Archives/edgar/data/1770069/000138832526000034/xslSCHEDULE_13D_X02/primary_doc.xml). The filing says neither the foundation nor the people listed in its schedule can direct the vote or sale of those shares. ## Context The 4.9% figure uses [42,618,165 shares outstanding at 2026-05-07, taken from MapLight's quarterly report filed on 2026-05-14](https://www.sec.gov/Archives/edgar/data/1770069/000138832526000034/xslSCHEDULE_13D_X02/primary_doc.xml). MapLight later [sold 9,197,887 more voting common shares in an August 2026 private placement](https://www.sec.gov/Archives/edgar/data/1770069/000119312526349490/d48818d8k.htm), so the same holding would be a smaller percentage of the later share count. Novo Holdings had been an investor before the IPO. MapLight's proxy statement shows it bought [19,734,671 Series D preferred shares in 2025](https://www.sec.gov/Archives/edgar/data/1770069/000119312526191449/d121249ddef14a.htm), and board member Jim Trenkle is a partner at Novo Holdings US, Inc., which provides consulting services to Novo Holdings A/S. The original Schedule 13D was filed on 2025-11-04, a week after the IPO closed on 2025-10-28. ## What it means for investors The filing is a reduction, not an exit: Novo Holdings still reported about 2.1 million shares. If the holding were unchanged, it would be about 3.8% of the [55,575,719 common shares, including non-voting shares, that MapLight reported outstanding at 2026-09-01](https://www.sec.gov/Archives/edgar/data/1770069/000119312526399452/d546679d424b3.htm) (our arithmetic). The filing gives no reason for the sales. The $12.00 block price was below the weighted-average prices of the other two groups sold that day, and below the [$17.00 IPO price of October 2025](https://www.sec.gov/Archives/edgar/data/1770069/000119312525255041/d89036d8k.htm). ## What to watch The amended schedule was [signed on 2026-07-31](https://www.sec.gov/Archives/edgar/data/1770069/000138832526000034/xslSCHEDULE_13D_X02/primary_doc.xml) by Barbara Fiorini, general counsel, finance and operations. The amendment does not describe plans for the remaining 2,086,622 shares. [Report an error](https://aibio.space/reputation/#correction) ## Companies in this story MPLT MapLight Therapeutics, Inc. NASDAQ ยท United States Open the starter desk ## More in Financings Financings ### [INmune Bio raises $4.50 million in registered direct offering with warrants](https://aibio.space/news/inmune-bio-raises-4-50-million-registered-direct-offering-warrants/) Oct 29, 2026 Financings ### [Lexeo Therapeutics files $300 million shelf registration](https://aibio.space/news/lexeo-therapeutics-files-300-million-shelf-registration/) Oct 29, 2026 Financings ### [ProKidney files $650 million shelf with $200 million Jefferies sales program](https://aibio.space/news/prokidney-files-650-million-shelf-200-million-jefferies-sales-program/) Oct 29, 2026 --- Source page: https://aibio.space/news/novo-holdings-cuts-maplight-stake-below-5-percent-after-july-30-share/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Novo Holdings cuts MapLight stake below 5%", 2026-07-30, https://aibio.space/news/novo-holdings-cuts-maplight-stake-below-5-percent-after-july-30-share/